Skip to content

Wednesday, October 28, 2026

Data from SEC filings, checked daily

Public filings, plainly told

About Method Sources Newsletter

Insider tradingForm 4

Avalo Therapeutics, Inc. (AVTX) Insider Trading

6 open-market trades reported since Aug 19, 2026: 0 purchases worth $0 and 6 sales worth $1.87M.

By insider

Insider	Role	Buys	Bought	Sells	Sold	Latest
Christopher Ryan Sullivan	CFO	0	$0	4	$1.83M	Sep 18, 2026
Mittie Doyle	Chief Medical Officer	0	$0	2	$34K	Sep 1, 2026

All trades

AVTX insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	3 mo. after	Filing
Sep 18	Sep 16	Christopher Ryan SullivanCFO	CFO	▼ SELL10b5-1	12,394	16.33	$202K	−24%		Form 4 ↗
Sep 11	Sep 10	Christopher Ryan SullivanCFO	CFO	▼ SELL10b5-1	10,185	17.62	$179K	−20%		Form 4 ↗
Sep 1	Aug 28	Mittie DoyleChief Medical Officer	Chief Medical Officer	▼ SELL10b5-1	679	20.00	$14K	−1.3%		Form 4 ↗
Aug 19	Aug 17	Christopher Ryan SullivanCFO	CFO	▼ SELL10b5-1	41,694	19.86	$828K	−51%		Form 4 ↗
Aug 19	Aug 18	Christopher Ryan SullivanCFO	CFO	▼ SELL10b5-1	31,031	20.05	$622K	−44%		Form 4 ↗
Aug 19	Aug 17	Mittie DoyleChief Medical Officer	Chief Medical Officer	▼ SELL10b5-1	1,000	20.00	$20K	−1.9%		Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings